Transcriptional regulation of human RANK ligand gene expression by E2F1

Biochemical and Biophysical Research Communications

Volumn 370, Issue 3, 2008, Pages 440-444

  Hu, Yan ^a   Sun, Meng ^b   Nadiminty, Nagalakshmi ^b   Lou, Wei ^b   Pinder, Elaine ^b   Gao, Allen C ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

E2F1; RANK; RANKL; Transcriptional regulation

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F1;

ARTICLE; BINDING SITE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DNA FLANKING REGION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNE FUNCTION TEST; MAMMARY GLAND; NUCLEOTIDE SEQUENCE; OSTEOLYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CONSENSUS SEQUENCE; DNA MUTATIONAL ANALYSIS; E2F1 TRANSCRIPTION FACTOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMANS; MUTATION; PROMOTER REGIONS (GENETICS); RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SEQUENCE DELETION; TRANSCRIPTION, GENETIC;

EID: 42749092575     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.106     Document Type: Article

References (19)

1. Takahashi N., Udagawa N., and Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 256 (1999) 449-455
2. Theill L.E., Boyle W.J., and Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20 (2002) 795-823
3. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., Teepe M.C., DuBose R.F., Cosman D., and Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390 (1997) 175-179
4. Chen G., Sircar K., Aprikian A., Potti A., Goltzman D., and Rabbani S.A. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 107 (2006) 289-298
5. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., and Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
6. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., and Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95 (1998) 3597-3602
7. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., Khoo W., Wakeham A., Dunstan C.R., Lacey D.L., Mak T.W., Boyle W.J., and Penninger J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (1999) 315-323
8. Seshasayee D., Wang H., Lee W.P., Gribling P., Ross J., Van Bruggen N., Carano R., and Grewal I.S. A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response. J. Biol. Chem. 279 (2004) 30202-30209
9. Fata J.E., Kong Y.Y., Li J., Sasaki T., Irie-Sasaki J., Moorehead R.A., Elliott R., Scully S., Voura E.B., Lacey D.L., Boyle W.J., Khokha R., and Penninger J.M. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103 (2000) 41-50
10. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C., Scully S., Tan H.L., Xu W., Lacey D.L., Boyle W.J., and Simonet W.S. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12 (1998) 1260-1268
11. Walsh M.C., and Choi Y. Biology of the TRANCE axis. Cytok. Growth Factor Rev. 14 (2003) 251-263
12. Kitazawa S., Kajimoto K., Kondo T., and Kitazawa R. Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. J. Cell Biochem. 89 (2003) 771-777
13. Kitazawa R., and Kitazawa S. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Biochem. Biophys. Res. Commun. 290 (2002) 650-655
14. Roccisana J.L., Kawanabe N., Kajiya H., Koide M., Roodman G.D., and Reddy S.V. Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells. J. Biol. Chem. 279 (2004) 10500-10507
15. Liu J., Yang H., Liu W., Cao X., and Feng X. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells. J. Cell Biochem. 96 (2005) 716-727
16. DeGregori J., and Johnson D.G. Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. Curr. Mol. Med. 6 (2006) 739-748
17. Tsantoulis P.K., and Gorgoulis V.G. Involvement of E2F transcription factor family in cancer. Eur. J. Cancer 41 (2005) 2403-2414
18. Slansky J.E., Li Y., Kaelin W.G., and Farnham P.J. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol. 13 (1993) 1610-1618
19. Farnham P.J., Slansky J.E., and Kollmar R. The role of E2F in the mammalian cell cycle. Biochim. Biophys. Acta. 1155 (1993) 125-131